Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 808

1.

Clinical significance of invasion distance relative to prognosis in pathological T3 colorectal cancer.

Nomura M, Takahashi H, Fujii M, Miyoshi N, Haraguchi N, Hata T, Matsuda C, Yamamoto H, Mizushima T, Mori M, Doki Y.

Oncol Lett. 2019 Nov;18(5):5614-5620. doi: 10.3892/ol.2019.10913. Epub 2019 Sep 24.

PMID:
31620203
2.

Predicting lateral pelvic lymph node metastasis based on magnetic resonance imaging before and after neoadjuvant chemotherapy for patients with locally advanced lower rectal cancer.

Sekido Y, Nishimura J, Fujino S, Ogino T, Miyoshi N, Takahashi H, Uemura M, Haraguchi N, Hata T, Matsuda C, Mizushima T, Murata K, Hasegawa J, Mori M, Doki Y.

Surg Today. 2019 Oct 8. doi: 10.1007/s00595-019-01886-7. [Epub ahead of print]

PMID:
31595366
3.

Development of Novel Prognostic Prediction Models including the Prognostic Nutritional Index for Patients with Colorectal Cancer after Curative Resection.

Sasaki M, Miyoshi N, Fujino S, Ishikawa S, Saso K, Takahashi H, Haraguchi N, Hata T, Matsuda C, Mizushima T, Doki Y, Mori M.

J Anus Rectum Colon. 2019 Jul 30;3(3):106-115. doi: 10.23922/jarc.2018-041. eCollection 2019.

4.

DCLK1 INTEGRATES INDUCTION OF TRIB3, EMT, DRUG RESISTANCE, and POOR PROGNOSIS IN COLORECTAL CANCER.

Makino S, Takahashi H, Okuzaki D, Miyoshi N, Haraguchi N, Hata T, Matsuda C, Yamamoto H, Mizushima T, Mori M, Doki Y.

Carcinogenesis. 2019 Sep 28. pii: bgz157. doi: 10.1093/carcin/bgz157. [Epub ahead of print]

PMID:
31562741
5.

Efficacy and safety of anticoagulant prophylaxis for prevention of postoperative venous thromboembolism in Japanese patients undergoing laparoscopic colorectal cancer surgery.

Hata T, Yasui M, Ikeda M, Miyake M, Ide Y, Okuyama M, Ikenaga M, Kitani K, Morita S, Matsuda C, Mizushima T, Yamamoto H, Murata K, Sekimoto M, Nezu R, Mori M, Doki Y; For Clinical Study Group of Osaka University Colorectal Group (CSGOCG) Investigators.

Ann Gastroenterol Surg. 2019 Jul 22;3(5):568-575. doi: 10.1002/ags3.12279. eCollection 2019 Sep.

6.

Role of glucocorticoid signaling in urothelial tumorigenesis: Inhibition by prednisone presumably through inducing glucocorticoid receptor transrepression.

Ide H, Inoue S, Mizushima T, Kashiwagi E, Zheng Y, Miyamoto H.

Mol Carcinog. 2019 Sep 18. doi: 10.1002/mc.23118. [Epub ahead of print]

PMID:
31535408
7.

Postoperative XELOX therapy for patients with curatively resected high-risk stage II and stage III rectal cancer without preoperative chemoradiation: a prospective, multicenter, open-label, single-arm phase II study.

Mizushima T, Ikeda M, Kato T, Ikeda A, Nishimura J, Hata T, Matsuda C, Satoh T, Mori M, Doki Y.

BMC Cancer. 2019 Sep 18;19(1):929. doi: 10.1186/s12885-019-6122-2.

8.

Correction to: Safety of Single-Site Laparoscopic Surgery Requiring Perioperative Heparinization in Colorectal Cancer: Propensity Score-Matched Analysis.

Iwamoto K, Takahashi H, Fujii M, Haraguchi N, Hata T, Matsuda C, Yamamoto H, Mizushima T, Mori M, Doki Y.

Ann Surg Oncol. 2019 Sep 17. doi: 10.1245/s10434-019-07839-1. [Epub ahead of print]

PMID:
31531795
9.

Efficacy and Long-term Peripheral Sensory Neuropathy of 3 vs 6 Months of Oxaliplatin-Based Adjuvant Chemotherapy for Colon Cancer: The ACHIEVE Phase 3 Randomized Clinical Trial.

Yoshino T, Yamanaka T, Oki E, Kotaka M, Manaka D, Eto T, Hasegawa J, Takagane A, Nakamura M, Kato T, Munemoto Y, Takeuchi S, Bando H, Taniguchi H, Gamoh M, Shiozawa M, Mizushima T, Saji S, Maehara Y, Ohtsu A, Mori M.

JAMA Oncol. 2019 Sep 12. doi: 10.1001/jamaoncol.2019.2572. [Epub ahead of print]

PMID:
31513248
10.

E-cadherin-Fc chimera protein matrix enhances cancer stem-like properties and induces mesenchymal features in colon cancer cells.

Qian Y, Wu X, Yokoyama Y, Okuzaki D, Taguchi M, Hirose H, Wang J, Hata T, Inoue A, Hiraki M, Ohtsuka M, Takahashi H, Haraguchi N, Mizushima T, Tanaka S, Mori M, Yamamoto H.

Cancer Sci. 2019 Sep 10. doi: 10.1111/cas.14193. [Epub ahead of print]

11.

Safety of Single-Site Laparoscopic Surgery Requiring Perioperative Heparinization in Colorectal Cancer: Propensity Score-Matched Analysis.

Iwamoto K, Takahashi H, Fujii M, Haraguchi N, Hata T, Matsuda C, Yamamoto H, Mizushima T, Mori M, Yuichiro D.

Ann Surg Oncol. 2019 Sep 6. doi: 10.1245/s10434-019-07794-x. [Epub ahead of print] Erratum in: Ann Surg Oncol. 2019 Sep 17;:.

PMID:
31493124
12.

Distinct methylation levels of mature microRNAs in gastrointestinal cancers.

Konno M, Koseki J, Asai A, Yamagata A, Shimamura T, Motooka D, Okuzaki D, Kawamoto K, Mizushima T, Eguchi H, Takiguchi S, Satoh T, Mimori K, Ochiya T, Doki Y, Ofusa K, Mori M, Ishii H.

Nat Commun. 2019 Aug 29;10(1):3888. doi: 10.1038/s41467-019-11826-1.

13.

Blood Flow Restriction Increases the Neural Activation of the Knee Extensors During Very Low-Intensity Leg Extension Exercise in Cardiovascular Patients: A Pilot Study.

Ishizaka H, Uematsu A, Mizushima Y, Nozawa N, Katayanagi S, Matsumoto K, Nishikawa K, Takahashi R, Arakawa T, Sawaguchi T, Yasuda T, Yamaguchi S, Ogawa H, Shibasaki I, Toyoda S, Hortobágyi T, Fukuda H, Inoue T, Mizushima T, Nakajima T.

J Clin Med. 2019 Aug 19;8(8). pii: E1252. doi: 10.3390/jcm8081252.

14.

The inflammation-nutrition score supports the prognostic prediction of the TNM stage for colorectal cancer patients after curative resection.

Fujino S, Myoshi N, Saso K, Sasaki M, Ishikawa S, Takahashi Y, Yasui M, Ohue M, Hata T, Matsuda C, Mizushima T, Mori M, Doki Y.

Surg Today. 2019 Aug 14. doi: 10.1007/s00595-019-01861-2. [Epub ahead of print]

PMID:
31414182
15.

Development of a Geriatric Prognostic Scoring System for Predicting Survival After Surgery for Elderly Patients With Gastrointestinal Cancer.

Yamasaki M, Maekawa Y, Sugimoto K, Mizushima T, Eguchi H, Ogihara T, Shintani A, Rakugi H, Mori M, Doki Y.

Ann Surg Oncol. 2019 Oct;26(11):3644-3651. doi: 10.1245/s10434-019-07687-z. Epub 2019 Aug 6.

PMID:
31388777
16.

Rate of Reoperation Decreased Significantly After Year 2002 in Patients With Crohn's Disease.

Shinagawa T, Hata K, Ikeuchi H, Fukushima K, Futami K, Sugita A, Uchino M, Watanabe K, Higashi D, Kimura H, Araki T, Mizushima T, Itabashi M, Ueda T, Koganei K, Oba K, Ishihara S, Suzuki Y.

Clin Gastroenterol Hepatol. 2019 Jul 20. pii: S1542-3565(19)30769-4. doi: 10.1016/j.cgh.2019.07.025. [Epub ahead of print]

PMID:
31336198
17.

Erratum: A novel prognostic prediction model for recurrence in patients with stage II colon cancer after curative resection.

Saso K, Myoshi N, Fujino S, Takenaka Y, Takahashi Y, Nishimura J, Yasui M, Ohue M, Tokuoka M, Ide Y, Takahashi H, Haraguchi N, Hata T, Matsuda C, Mizushima T, Doki Y, Mori M.

Mol Clin Oncol. 2019 Aug;11(2):213. doi: 10.3892/mco.2019.1879. Epub 2019 Jun 13.

18.

Changes in the rate of and trends in colectomy for ulcerative colitis during the era of biologics and calcineurin inhibitors based on a Japanese nationwide cohort study.

Uchino M, Ikeuchi H, Hata K, Okada S, Ishihara S, Morimoto K, Sahara R, Watanabe K, Fukushima K, Takahashi K, Kimura H, Hirata K, Mizushima T, Araki T, Kusunoki M, Nezu R, Nakao S, Itabashi M, Hirata A, Ozawa H, Ishida T, Okabayashi K, Yamamoto T, Noake T, Arakaki J, Watadani Y, Ohge H, Futatsuki R, Koganei K, Sugita A, Higashi D, Futami K.

Surg Today. 2019 Jul 15. doi: 10.1007/s00595-019-01845-2. [Epub ahead of print]

PMID:
31309329
19.

Validity and Reliability of a 2-Min Walk Test to Assess the Exercise Capacity in Vertebral Compression Fracture Patients: A Pilot Study.

Goda A, Morishima Y, Yokohara N, Suzuki T, Ohgi S, Mizushima T.

Phys Ther Res. 2019 Mar 11;22(1):26-30. doi: 10.1298/ptr.E9958. eCollection 2019.

20.

A Phase I Study of Neoadjuvant Capecitabine, Oxaliplatin, and Irinotecan (XELOXIRI) in Patients with Locally Advanced Rectal Cancer.

Kudo T, Takemasa I, Hata T, Sakai D, Takahashi H, Haraguchi N, Nishimura J, Hata T, Matsuda C, Satoh T, Mizushima T, Mori M, Doki Y.

Oncology. 2019;97(4):211-216. doi: 10.1159/000500677. Epub 2019 Jul 2.

PMID:
31266024
21.

Chemical modification-mediated optimisation of bronchodilatory activity of mepenzolate, a muscarinic receptor antagonist with anti-inflammatory activity.

Yamashita Y, Tanaka KI, Yamakawa N, Asano T, Kanda Y, Takafuji A, Kawahara M, Takenaga M, Fukunishi Y, Mizushima T.

Bioorg Med Chem. 2019 Aug 1;27(15):3339-3346. doi: 10.1016/j.bmc.2019.06.016. Epub 2019 Jun 8.

PMID:
31204225
22.

Adalimumab Dose-Escalation Therapy Is Effective in Refractory Crohn's Disease Patients with Loss of Response to Adalimumab, Especially in Cases without Previous Infliximab Treatment.

Suzuki T, Mizoshita T, Sugiyama T, Hirata Y, Kimura Y, Suzuki Y, Yamada T, Tsukamoto H, Mizushima T, Sugimura N, Katano T, Tanida S, Kataoka H, Sasaki M.

Case Rep Gastroenterol. 2019 Feb 6;13(1):37-49. doi: 10.1159/000496453. eCollection 2019 Jan-Apr.

23.

Survival outcomes of appendiceal mucinous neoplasms by histological type and stage: Analysis of 266 cases in a multicenter collaborative retrospective clinical study.

Sueda T, Murata K, Takeda T, Kagawa Y, Hasegawa J, Komori T, Noura S, Ikeda K, Tsujie M, Ohue M, Ota H, Ikenaga M, Hata T, Matsuda C, Mizushima T, Yamamoto H, Sekimoto M, Nezu R, Mori M, Doki Y.

Ann Gastroenterol Surg. 2019 Feb 25;3(3):291-300. doi: 10.1002/ags3.12241. eCollection 2019 May.

24.

Changes of Dyspeptic Symptom after Successful Eradication in Helicobacter pylori-Associated Dyspepsia.

Tsuda M, Kato M, Ono S, Matsuda K, Miyamoto S, Abiko S, Ono M, Mizushima T, Yamamoto K, Nakagawa M, Mabe K, Nakagawa S, Kudo T, Nishikawa K, Shimizu Y, Asaka M, Sakamoto N.

Digestion. 2019 Apr 16:1-9. doi: 10.1159/000497432. [Epub ahead of print]

PMID:
30991388
25.

Phenotypic heterogeneity of 2D organoid reflects clinical tumor characteristics.

Fujino S, Ito A, Ohue M, Yasui M, Mizushima T, Doki Y, Mori M, Miyoshi N.

Biochem Biophys Res Commun. 2019 May 28;513(2):332-339. doi: 10.1016/j.bbrc.2019.03.173. Epub 2019 Apr 5.

PMID:
30955861
26.

A rare case of pelvic bronchogenic cyst treated by laparoscopic surgery.

Tokuyama S, Takahashi H, Miyoshi N, Haraguchi N, Hata T, Matsuda C, Yamamoto H, Mizushima T, Mori M, Doki Y.

Asian J Endosc Surg. 2019 Apr 3. doi: 10.1111/ases.12708. [Epub ahead of print]

PMID:
30945471
27.

Sugar-Recognizing Ubiquitin Ligases: Action Mechanisms and Physiology.

Yoshida Y, Mizushima T, Tanaka K.

Front Physiol. 2019 Feb 19;10:104. doi: 10.3389/fphys.2019.00104. eCollection 2019. Review.

28.

Cumulative Inflammation Could Be a Risk Factor for Intestinal Failure in Crohn's Disease.

Watanabe Y, Miyoshi N, Fujino S, Takahashi H, Haraguchi N, Hata T, Matsuda C, Yamamoto H, Doki Y, Mori M, Mizushima T.

Dig Dis Sci. 2019 Aug;64(8):2280-2285. doi: 10.1007/s10620-019-05553-2. Epub 2019 Feb 26.

PMID:
30806860
29.

The Role of Androgen Receptor Signaling in Ovarian Cancer.

Mizushima T, Miyamoto H.

Cells. 2019 Feb 19;8(2). pii: E176. doi: 10.3390/cells8020176. Review.

30.

Disruption of Endolysosomal RAB5/7 Efficiently Eliminates Colorectal Cancer Stem Cells.

Takeda M, Koseki J, Takahashi H, Miyoshi N, Nishida N, Nishimura J, Hata T, Matsuda C, Mizushima T, Yamamoto H, Ishii H, Doki Y, Mori M, Haraguchi N.

Cancer Res. 2019 Apr 1;79(7):1426-1437. doi: 10.1158/0008-5472.CAN-18-2192. Epub 2019 Feb 14.

PMID:
30765602
31.

Surveillance Colonoscopy for Ulcerative Colitis-Associated Colorectal Cancer Offers Better Overall Survival in Real-World Surgically Resected Cases.

Hata K, Anzai H, Ikeuchi H, Futami K, Fukushima K, Sugita A, Uchino M, Higashi D, Itabashi M, Watanabe K, Koganei K, Araki T, Kimura H, Mizushima T, Ueda T, Ishihara S, Suzuki Y; Research Group for Intractable Inflammatory Bowel Disease of the Ministry of Health, Labour and Welfare of Japan (RGIBD).

Am J Gastroenterol. 2019 Mar;114(3):483-489. doi: 10.14309/ajg.0000000000000117.

PMID:
30747769
32.

The association between the increased performance of laparoscopic colon surgery and a reduced risk of surgical site infection.

Kagawa Y, Yamada D, Yamasaki M, Miyamoto A, Mizushima T, Yamabe K, Imazato M, Fukunaga H, Kobayashi S, Shimizu J, Umeshita K, Ito T, Doki Y, Mori M.

Surg Today. 2019 Jun;49(6):474-481. doi: 10.1007/s00595-019-1760-1. Epub 2019 Jan 25.

33.

Forkhead box O1 as an indicator of prognosis is inactivated in urothelial carcinoma of the upper urinary tract.

Ide H, Jiang G, Mizushima T, Fujita K, Inoue S, Yamaguchi S, Fushimi H, Nonomura N, Miyamoto H.

Oncol Lett. 2019 Jan;17(1):482-487. doi: 10.3892/ol.2018.9510. Epub 2018 Sep 26.

34.

Chemically Modified Antisense Oligonucleotide Against ARL4C Inhibits Primary and Metastatic Liver Tumor Growth.

Harada T, Matsumoto S, Hirota S, Kimura H, Fujii S, Kasahara Y, Gon H, Yoshida T, Itoh T, Haraguchi N, Mizushima T, Noda T, Eguchi H, Nojima S, Morii E, Fukumoto T, Obika S, Kikuchi A.

Mol Cancer Ther. 2019 Mar;18(3):602-612. doi: 10.1158/1535-7163.MCT-18-0824. Epub 2019 Jan 15.

PMID:
30647122
35.

Involvement of MAF1 homolog, negative regulator of RNA polymerase III in colorectal cancer progression.

Hokonohara K, Nishida N, Miyoshi N, Takahashi H, Haraguchi N, Hata T, Matsuda C, Mizushima T, Doki Y, Mori M.

Int J Oncol. 2019 Mar;54(3):1001-1009. doi: 10.3892/ijo.2019.4678. Epub 2019 Jan 7.

36.

A Novel Predictive Nomogram for Early Endoscopic Recurrence after Intestinal Resection for Crohn's Disease.

Ikeda A, Miyoshi N, Fujino S, Iijima H, Takahashi H, Haraguchi N, Nishimura J, Hata T, Matsuda C, Doki Y, Mori M, Mizushima T.

Digestion. 2019 Jan 2:1-8. doi: 10.1159/000495981. [Epub ahead of print]

PMID:
30602165
37.

Factors predictive of high-output ileostomy: a retrospective single-center comparative study.

Takeda M, Takahashi H, Haraguchi N, Miyoshi N, Hata T, Yamamoto H, Matsuda C, Mizushima T, Doki Y, Mori M.

Surg Today. 2019 Jun;49(6):482-487. doi: 10.1007/s00595-018-1756-2. Epub 2018 Dec 29.

38.

Fatty Acid β-Oxidation-dependent and -independent Responses and Tumor Aggressiveness Acquired Under Mild Hypoxia.

Wakui M, Kawai K, Mizushima T, Nishime C, Serizawa A, Suemizu H, Asakura K, Yamauchi Y, Hayashida T, Suematsu M, Murata M.

Anticancer Res. 2019 Jan;39(1):191-200. doi: 10.21873/anticanres.13097.

PMID:
30591458
39.

ELK1 promotes urothelial tumorigenesis in the presence of an activated androgen receptor.

Inoue S, Ide H, Mizushima T, Jiang G, Kawahara T, Miyamoto H.

Am J Cancer Res. 2018 Nov 1;8(11):2325-2336. eCollection 2018.

40.

Expression of erythropoietin messenger ribonucleic acid in wild-type MED12 uterine leiomyomas under estrogenic influence: new insights into related growth disparities.

Asano R, Asai-Sato M, Matsukuma S, Mizushima T, Taguri M, Yoshihara M, Inada M, Fukui A, Suzuki Y, Miyagi Y, Miyagi E.

Fertil Steril. 2019 Jan;111(1):178-185. doi: 10.1016/j.fertnstert.2018.09.014. Epub 2018 Dec 13.

PMID:
30554729
41.

A novel prognostic prediction model for recurrence in patients with stage II colon cancer after curative resection.

Saso K, Myoshi N, Fujino S, Takenaka Y, Takahashi Y, Nishimura J, Yasui M, Ohue M, Tokuoka M, Ide Y, Takahashi H, Haraguchi N, Hata T, Matsuda C, Mizushima T, Doki Y, Mori M.

Mol Clin Oncol. 2018 Dec;9(6):697-701. doi: 10.3892/mco.2018.1733. Epub 2018 Oct 4. Erratum in: Mol Clin Oncol. 2019 Aug;11(2):213.

42.

Cancer stem cells in relation to treatment.

Miyoshi N, Mizushima T, Doki Y, Mori M.

Jpn J Clin Oncol. 2019 Mar 1;49(3):232-237. doi: 10.1093/jjco/hyy186. Review.

PMID:
30541049
43.

Antinociception by fluoro-loxoprofen, a novel non-steroidal anti-inflammatory drug with less ulcerogenic effects, in rat models of inflammatory pain.

Asano T, Hattori T, Tanaka KI, Yamakawa N, Suemasu S, Aida S, Kataoka M, Mizushima T, Takenaga M.

Eur J Pharmacol. 2019 Feb 5;844:253-258. doi: 10.1016/j.ejphar.2018.12.008. Epub 2018 Dec 6.

PMID:
30529473
44.

ATF2 promotes urothelial cancer outgrowth via cooperation with androgen receptor signaling.

Inoue S, Mizushima T, Ide H, Jiang G, Goto T, Nagata Y, Netto GJ, Miyamoto H.

Endocr Connect. 2018 Dec 1;7(12):1397-1408. doi: 10.1530/EC-18-0364.

45.

Sox2 is associated with cancer stem-like properties in colorectal cancer.

Takeda K, Mizushima T, Yokoyama Y, Hirose H, Wu X, Qian Y, Ikehata K, Miyoshi N, Takahashi H, Haraguchi N, Hata T, Matsuda C, Doki Y, Mori M, Yamamoto H.

Sci Rep. 2018 Dec 5;8(1):17639. doi: 10.1038/s41598-018-36251-0.

46.

Negative Thermal Magnetoresistivity as a Signature of a Chiral Anomaly in Weyl Superconductors.

Kobayashi T, Matsushita T, Mizushima T, Tsuruta A, Fujimoto S.

Phys Rev Lett. 2018 Nov 16;121(20):207002. doi: 10.1103/PhysRevLett.121.207002.

PMID:
30500245
47.

Long-term outcomes following restorative proctocolectomy ileal pouch-anal anastomosis in pediatric ulcerative colitis patients: Multicenter national study in Japan.

Ikeuchi H, Uchino M, Sugita A, Futami K, Fukushima K, Hata K, Koganei K, Kusunoki M, Uchida K, Nezu R, Kimura H, Takahashi K, Itabashi M, Kameyama H, Higashi D, Koyama F, Ueda T, Mizushima T, Suzuki Y.

Ann Gastroenterol Surg. 2018 Jul 27;2(6):428-433. doi: 10.1002/ags3.12198. eCollection 2018 Nov.

48.

Innate Myeloid Cell Subset-Specific Gene Expression Patterns in the Human Colon are Altered in Crohn's Disease Patients.

Sekido Y, Yasumizu Y, Nishimura J, Kayama H, Matsuno H, Ogino T, Miyoshi N, Takahashi H, Haraguchi N, Hata T, Matsuda C, Doki Y, Mori M, Takeda K, Ohkura N, Sakaguchi S, Mizushima T.

Digestion. 2019;99(3):194-204. doi: 10.1159/000490890. Epub 2018 Oct 19.

PMID:
30343293
49.

Normalization of abnormal plasma amino acid profile-based indexes in patients with gynecological malignant tumors after curative treatment.

Suzuki Y, Tokinaga-Uchiyama A, Mizushima T, Maruyama Y, Mogami T, Shikata N, Ikeda A, Yamamoto H, Miyagi E.

BMC Cancer. 2018 Oct 12;18(1):973. doi: 10.1186/s12885-018-4875-7.

50.

Structure of glyoxysomal malate dehydrogenase (MDH3) from Saccharomyces cerevisiae.

Moriyama S, Nishio K, Mizushima T.

Acta Crystallogr F Struct Biol Commun. 2018 Oct 1;74(Pt 10):617-624. doi: 10.1107/S2053230X18011895. Epub 2018 Sep 19.

PMID:
30279312

Supplemental Content

Loading ...
Support Center